Alcoholic hepatitis: How far are we and where are we going?
Título del documento: Alcoholic hepatitis: How far are we and where are we going?
Revista: Annals of hepatology
Base de datos: PERIÓDICA
Número de sistema: 000407467
ISSN: 1665-2681
Autors: 1
1
2
3
2
Institucions: 1Hospital Clinic de Barcelona, Unidad de Cuidados Intensivos, Barcelona. España
2Universidad Autónoma de Barcelona, Hospital Vall d'Hebron, Barcelona. España
3University of North Carolina, Division of Gastroenterology and Hepatology, Chapel Hill, Carolina del Norte. Estados Unidos de América
Any:
Període: Jul-Ago
Volum: 15
Número: 4
Paginació: 463-473
País: México
Idioma: Inglés
Tipo de documento: Artículo
Enfoque: Analítico, descriptivo
Resumen en inglés The burden of alcoholic liver disease continues to be a major public health problem worldwide. The spectrum of disease ranges from fatty liver to cirrhosis and hepatocellular carcinoma. Alcoholic hepatitis (AH) is a type of acute-on-chronic liver failure and the most severe form of alcoholic liver disease. Severe AH carries a poor short-term prognosis and its management is still challenging, with scarce advances in the last decades. Corticosteroids are still the first line of therapy in severe cases. Unfortunately, many patients do not respond and novel targeted therapies are urgently needed. Liver transplantation has shown extraordinary results in non-responders to corticosteroids however; its applicability is very low. This review summarizes the epidemiology, natural history, risk factors and pathogenesis of alcoholic liver disease with special focus on the latest advances in prognostic stratification and therapy of patients with alcoholic hepatitis
Disciplines Medicina
Paraules clau: Gastroenterología,
Toxicología,
Hepatitis alcohólica,
Esteatohepatitis,
Patogénesis,
Factores de riesgo,
Corticosteroides
Keyword: Medicine,
Gastroenterology,
Toxicology,
Alcoholic hepatitis,
Steatohepatitis,
Pathogenesis,
Risk factors,
Corticosteroids
Text complet: Texto completo (Ver PDF)